News

Biogen Idec appoints EVP global commercial operations

BY Allison Cerra

WESTON, Mass. — Biogen Idec has appointed Tony Kingsley as its new EVP global commercial operations.

Kingsley, who will transition to his new role Nov. 7, will oversee development and execution of Biogen Idec’s global commercial business strategies. In his current role as SVP U.S. commercial operations, a capacity he has served in since January 2010, he is responsible for all U.S. commercial functions, including marketing, sales, market access, patient services, training and sales operations.

Kingsley will report to Biogen Idec CEO George Scangos.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

APhA encourages patients to talk to pharmacists about pain, pain drugs

BY Alaric DeArment

WASHINGTON — The American Pharmacists Association is marking Pain Awareness Month by encouraging patients to talk with their pharmacists about pain and pain medications they’re taking.

According to a recent report by the Institute of Medicine, more than 116 million Americans suffer from chronic pain, which costs the country up to $635 billion per year.

The APhA said that numerous medication therapies are available for pain, and as medication experts, pharmacists are able to work with patients, their physicians and other healthcare providers to ensure that patients use the appropriate medications, that they understand how to use them and achieve the best outcomes.


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Global gluten-free product sales to surpass $3 billion by 2015

BY Allison Cerra

NEW YORK — The gluten-free products market continues to grow at a rapid pace, according to a Euromonitor International forecast.

The research firm projected that 2011 gluten-free sales of $1.31 billion in the United States, more than doubling since 2005. Additionally, global sales of gluten-free items are expected to total $2.67 billion for the year, Euromonitor International said.

By 2015, U.S. gluten-free product sales are expected to garner $1.68 billion, with sales reaching $3.38 billion globally.

"Consumers do feel some sort of reward when they eat gluten-free products. They don’t feel bloated. They don’t have belly aches. This usually encourages them to repeat the purchase," Euromonitor International’s head of health and wellness research Ewa Hudson said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?